Chen Shu-Chih

Atossa Therapeutics, Inc.

Director

Avg. Two Year Performance

(90%) Avg. Purchase Return (38%) Compound

87% Avg. Sale Return 37% Compound

Holdings: 4.35M shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions